Align Financial’s Teladoc Health TDOC Stock Holding History

Align Financial’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100	Closed	-$545	–	375
2026 Q1	$545	Sell	100 -600	-86%	-$3.37K	﹤0.01%	354
2025 Q4	$700	Buy	+700	New	+$5.48K	﹤0.01%	367

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Align Financial's TDOC Position: Q2 2026 in Review

Align Financial sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 100 shares — an estimated $545 sold.

Align Financial first reported a position in TDOC in Q4 2025 and held it in 2 quarters. The position peaked at $700 in Q4 2025. 346 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Align Financial reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
Align Financial sold 100 Teladoc Health shares in Q2 2026, an estimated $545.
Align Financial first reported a position in Teladoc Health in Q4 2025 and held it in 2 quarters.
Align Financial's Teladoc Health position peaked at $700 in Q4 2025.
346 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Align Financial's 13F filing for Q2 2026, filed 27 Jul 2026.